RT @PlaysForTheDay: I've been tweeting about $NWBO since 2020- so happy to have been able to help a company succeed in extending Cancer pat…

RT @HassanClan: "Murcidencel ["DCVax-L" developed by Northwest Biotherapuetics right here in Bethesda] also ranks one of the most commercia…

RT @Onco_Jock: Loving this podcast on the JAMA Oncology website, especially the point at 11:13 where Dr. Linda Liau notes that the safety p…

@juliaskripkaser HAHAHAHA JAMA! https://t.co/p1b6kj9U2W

@adamfeuerstein OOPS! You forgot to block me!! I hope you’re exposed for the fraud we know you are!!! #JAMA! $NWBO https://t.co/p1b6kj9U2W

RT @GaladonGaming: CONGRATS to $NWBO, its shareholders, and more importantly cancer patients around the world! https://t.co/OOhkBH26gI #N…

RT @EveryTrade: https://t.co/EgkZhy9Q3e $NWBO #murcidencel

@Toms11Steven @Hygro10 @adamfeuerstein JAMA! You owe the good Dr @Toms11Steven an apology!!! https://t.co/p1b6kiSiEm

@Toms11Steven @adamfeuerstein JAMA BABY! Adam, you owe the good Dr an apology! https://t.co/p1b6kj9U2W

@Jordongf2 @statnews @adamfeuerstein JAMA!!! https://t.co/p1b6kj9U2W

@adamfeuerstein @Hygro10 JAMA upon BOTH of your houses!!! HAHAHAHA https://t.co/p1b6kj9U2W

@Hygro10 Oh we no desperate Hygro…we JAMA https://t.co/p1b6kj9U2W

@Hygro10 @Hugo_Soucy @IamBreastCancer @adamfeuerstein JAMA SAID WHAT?!? https://t.co/p1b6kj9U2W

@Hygro10 JAMA https://t.co/p1b6kj9U2W

@Hygro10 JAMA HYGRO!! Read it and cry like a baby!!! https://t.co/p1b6kj9U2W

@Hygro10 JAMA https://t.co/p1b6kiSiEm

@Hygro10 No one reads your BS Loser! JAMA https://t.co/p1b6kj9U2W

@Hygro10 HAHAHAJAMAHAHAHA https://t.co/p1b6kj9U2W

@Hygro10 JAMA!!!!! https://t.co/p1b6kj9U2W

@BulwarkOnline @Hygro10 JAMA https://t.co/p1b6kj9U2W

@Hygro10 @Hugo_Soucy @IamBreastCancer @adamfeuerstein JAMA JAMA JAMA https://t.co/p1b6kj9U2W

@Hygro10 @MC17595091 @SEC_Enforcement JAMA BABY!!!! https://t.co/p1b6kj9U2W

@Hygro10 @MC17595091 @SEC_Enforcement https://t.co/p1b6kj9U2W

@Hygro10 HAHAHAHAHAHA JAMA FOOL! https://t.co/p1b6kj9U2W

@adamfeuerstein @TwitterSupport @juliaskripkaser JAMA. 💣 💥 😘 In this study, adding DCVax-L to SOC resulted in clinically meaningful and statistically significant extension of survival for patients with both nGBM and rGBM compared with contemporaneous, mat

One of the first Phase 3 studies to show survival benefit for those with recurrent GBM, and also newly diagnosed GBM. A step forward 🙌🏼👏🏼 Association of DCVax-L With Extension of Survival Among Patients With Glioblastoma https://t.co/EQfEqfe6Hy via @JAMAO

RT @jonathan5tymes: Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally…

RT @jonathan5tymes: Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally…

RT @metacollectiveG: $NWBO New Online JAMA Oncology!! Listen to the little speaker button for interview with Dr Liau! https://t.co/aTttMPbF…

Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial | Neuro-oncology | JAMA Oncology | JAMA Network $NWBO https://t.co/7fQBVa36WC

RT @MDendream: Word up! $NWBO

Autologous tumor lysate-loaded dendritic cell vaccine (DCVax-L) plus standard of care (SOC) significantly improved overall survival among patients with newly diagnosed and recurrent GBM with minimal toxicity. https://t.co/POFg9uVFuY https://t.co/ziaWHJCvGD

RT @MHill771: https://t.co/PiEgMvJkW8 what’s a revolutionary cancer treatment worth? $NWBO

Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial | Neuro-oncology | JAMA Oncology |

RT @romeerizwan: Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Ne…

RT @metacollectiveG: $NWBO New Online JAMA Oncology!! Listen to the little speaker button for interview with Dr Liau! https://t.co/aTttMPbF…

RT @TiltMyBrain: https://t.co/iS4m5IwtxG. $NWBO Boom!

RT @HenryMuney: JAMA article is published and Dr. Linda Liau interview! $NWBO #DCVax-L 1. https://t.co/pfRDJSM1lP 2. https://t.co/O1rkNG8t…

Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial https://t.co/2qR3sOg6Ve

RT @rago_carlo: $NWBO JAMA article out today describing their P3 clinical trial wins in newly diagnosed AND recurrent GBM!! https://t.co/9…

RT @rago_carlo: $NWBO JAMA article out today describing their P3 clinical trial wins in newly diagnosed AND recurrent GBM!! https://t.co/9…

RT @HenryMuney: JAMA article is published and Dr. Linda Liau interview! $NWBO #DCVax-L 1. https://t.co/pfRDJSM1lP 2. https://t.co/O1rkNG8t…

Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial https://t.co/nLRuut5V3E

Word up! $NWBO

Oh my. $nwbo

#NWBO #DCVax #murcidencel @ChrisPlanteShow @VinceCoglianese @WMALDC Right here in Bethesda, MD "... ranks one of the most commercially and medically important drugs ever developed by the biopharma industry." (MicroCap Daily) $nwbo https://t.co/CPmtXODAz4

RT @EANOassociation: Association of DCVax-L With Extension of Survival Among Patients With #Glioblastoma. https://t.co/2NsDsrfCu4 #btsm @…

"Murcidencel ["DCVax-L" developed by Northwest Biotherapuetics right here in Bethesda] also ranks one of the most commercially and medically important drugs ever developed by the biopharma industry." $nwbo https://t.co/CPmtXODAz4 @ChrisPlanteShow @wmalnew

RT @peterjkostis: The moment we have all been waiting for! Confirmation that Murcidencel works and will most likely become a new SOC. Congr…

RT @Onco_Jock: Loving this podcast on the JAMA Oncology website, especially the point at 11:13 where Dr. Linda Liau notes that the safety p…

RT @biggercapital: https://t.co/rre6ASD01D $NWBO JAMA > @statnews #GBM

https://t.co/TaXEH2jLqZ

@celltherapy @adamfeuerstein You can listen to liaus explanation at JAMA. They tried hard to work around the issue of Pseudo-progression. Endpoints were changed before unblinding. SAP plan same wording as Pazdurs article on ECA. https://t.co/rJs5g7UgiQ

RT @metacollectiveG: $NWBO New Online JAMA Oncology!! Listen to the little speaker button for interview with Dr Liau! https://t.co/aTttMPbF…

Association of DCVax-L With Extension of Survival Among Patients With #Glioblastoma. https://t.co/2NsDsrfCu4 #btsm @JAMAOnc @JAMANetwork

RT @celltherapy: Despite its many, many detractors, Northwest Biotherapeutics ($NWBO) appears to be gaining traction after FINALLY publish…

Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial | JAMA Oncology | JAMA Network http

Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: https://t.co/AopNWh5Tmp

RT @AlMusella: https://t.co/sowFiBVVhA The DCVAX peer reviewed journal article is now available online! #DCVAX #SNO2022 #GBM

RT @eastvillagetwt: For $NWBO the next set of issues should be, what big pharma companies will need to do deals with them to 1) enhance the…

RT @rweinmann27891: https://t.co/8Ld6vCNZ0g $NWBO its happening

Impressive gains in survival for both newly-diagnosed and recurrent GBM patients with this autologous dendritic cell vaccine therapy #glioblastoma #BTSNZ #braintumour

@cnnbrk @drsanjaygupta breakthrough in #GBM announced today! https://t.co/JZ5zdLgL0d

Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma #BTSM #BrainTumorThursday https://t.co/g1ySkKVNCm

RT @biggercapital: https://t.co/rre6ASD01D $NWBO JAMA > @statnews #GBM

RT @AlMusella: https://t.co/sowFiBVVhA The DCVAX peer reviewed journal article is now available online! #DCVAX #SNO2022 #GBM

RT @HenryMuney: JAMA article is published and Dr. Linda Liau interview! $NWBO #DCVax-L 1. https://t.co/pfRDJSM1lP 2. https://t.co/O1rkNG8t…

RT @eastvillagetwt: For $NWBO the next set of issues should be, what big pharma companies will need to do deals with them to 1) enhance the…

RT @peterjkostis: The moment we have all been waiting for! Confirmation that Murcidencel works and will most likely become a new SOC. Congr…

For $NWBO the next set of issues should be, what big pharma companies will need to do deals with them to 1) enhance the efficacy of their own immunotherapies; and 2) what patents, e.g. Keytruda, might expire?

RT @Onco_Jock: Loving this podcast on the JAMA Oncology website, especially the point at 11:13 where Dr. Linda Liau notes that the safety p…

RT @rago_carlo: $NWBO JAMA article out today describing their P3 clinical trial wins in newly diagnosed AND recurrent GBM!! https://t.co/9…

RT @celltherapy: Despite its many, many detractors, Northwest Biotherapeutics ($NWBO) appears to be gaining traction after FINALLY publish…

RT @metacollectiveG: $NWBO New Online JAMA Oncology!! Listen to the little speaker button for interview with Dr Liau! https://t.co/aTttMPbF…

RT @TVRoyale: @adamfeuerstein @statnews You ready for handcuffs yet, Adam? Not the fuzzy ones, either... @SECEnfDirector surely knows the…

RT @shawnkothari: Look forward to discussing at SNO. How will we interpret the use of the external control? @StevenBremMD @EKNduom Assoc…

RT @MDCearns: Hot off the press 4 hours ago… Trial evidence of survival benefit particularly for recurrent #glioblastoma from a dendritic…

RT @MrRoccoRusso: $NWBO BOOOOM! https://t.co/10Zzakim8P

RT @peterjkostis: The moment we have all been waiting for! Confirmation that Murcidencel works and will most likely become a new SOC. Congr…

@adamfeuerstein @statnews You ready for handcuffs yet, Adam? Not the fuzzy ones, either... @SECEnfDirector surely knows the name "Adam Feuerstein" by now! Your lies, deceit and misdeeds are finally catching up with you. $NWBO https://t.co/buZdpjPHZL

Hot off the press 4 hours ago… Trial evidence of survival benefit particularly for recurrent #glioblastoma from a dendritic cell vaccine. Evidence that #immunotherapy approaches are worth pursuing! Congrats to Dr Liau and colleagues. https://t.co/Td3aK4s

RT @peterjkostis: The moment we have all been waiting for! Confirmation that Murcidencel works and will most likely become a new SOC. Congr…

RT @peterjkostis: The moment we have all been waiting for! Confirmation that Murcidencel works and will most likely become a new SOC. Congr…

RT @FlemmingBruce: $NWBO JAMA journal 🚀

The moment we have all been waiting for! Confirmation that Murcidencel works and will most likely become a new SOC. Congrats to Dr. Liau and Co. To those who tried to derail this for profit.... bend over!

I've been tweeting about $NWBO since 2020- so happy to have been able to help a company succeed in extending Cancer patients lives- now vindicated by a peer-reviewed paper in JAMA Oncology: https://t.co/Sk1LV30kVT

RT @GaladonGaming: CONGRATS to $NWBO, its shareholders, and more importantly cancer patients around the world! https://t.co/OOhkBH26gI #N…

RT @EveryTrade: $NWBO #murcidencel Some Burger Today! Can't take it all in one bite. https://t.co/EgkZhy9Q3e https://t.co/nM6S2QA6NV

Loving this podcast on the JAMA Oncology website, especially the point at 11:13 where Dr. Linda Liau notes that the safety profile of #murcidencel is "exceptionally benign." So very important to patients and their caregivers! $NWBO https://t.co/qsJYXWntjI

RT @rago_carlo: $NWBO JAMA article out today describing their P3 clinical trial wins in newly diagnosed AND recurrent GBM!! https://t.co/9…

RT @metacollectiveG: $NWBO New Online JAMA Oncology!! Listen to the little speaker button for interview with Dr Liau! https://t.co/aTttMPbF…

#NWBO has the secret sauce... validated by JAMA: https://t.co/kLHpSzE65Z https://t.co/egh23p182P

RT @biggercapital: https://t.co/rre6ASD01D $NWBO JAMA > @statnews #GBM

RT @HenryMuney: JAMA article is published and Dr. Linda Liau interview! $NWBO #DCVax-L 1. https://t.co/pfRDJSM1lP 2. https://t.co/O1rkNG8t…

Despite its many, many detractors, Northwest Biotherapeutics ($NWBO) appears to be gaining traction after FINALLY publishing data from its phase III study in glioblastoma of its legacy dendritic cell immunotherapy in JAMA Oncology. https://t.co/dZDNCfSygP

RT @metacollectiveG: $NWBO New Online JAMA Oncology!! Listen to the little speaker button for interview with Dr Liau! https://t.co/aTttMPbF…

RT @metacollectiveG: @hoffmann6383 $NWBO Embargo’s lifted. The Media frenzy will start https://t.co/aTttMPbFnn

https://t.co/2CfBr3QNOq Where were you when your ship came in?

RT @HenryMuney: JAMA article is published and Dr. Linda Liau interview! $NWBO #DCVax-L 1. https://t.co/pfRDJSM1lP 2. https://t.co/O1rkNG8t…

Look forward to discussing at SNO. How will we interpret the use of the external control? @StevenBremMD @EKNduom Association of DCVax-L With Extension of Survival Among Patients With Glioblastoma https://t.co/lOfpim3lky via @JAMAOnc part of @JAMANetwork